Investors Alert on OTC Stocks - Federal Home Loan Mortgage, mPhase Technologies, Growlife, AMARANTUS BIOSCI

Birmingham, West Midlands -- (SBWIRE) -- 03/06/2013 -- Value Penny Stocks issues special report on the Top movers – Federal Home Loan Mortgage Corp (OTC:FMCC), mPhase Technologies, Inc.(OTC:XDSL), Growlife Inc (OTC:PHOT), AMARANTUS BIOSCI INC (OTC:AMBS)

Federal Home Loan Mortgage Corp (OTC:FMCC) was trading lower by -0.009 points or -2.56% to 0.331.So far, around 3.83 million shares has changed hands in this session. After opening at $0.33, the stock hit as high as $0.34. However, it traded between $0.14 and $0.34 over the last twelve months. The Federal Home Loan Mortgage Corporation provides credit guarantee for residential mortgages originated by mortgage lenders and invests in mortgage loans and mortgage-related securities in the United States.

Has FMCC Found The Bottom and Ready To Move Up? Find Out Here

mPhase Technologies, Inc.(OTC:XDSL) was at $0.0030, showing a -9.09% decrease. Around 3.32 million shares have been traded, versus an-average trading volume of 4.80 shares. The company is now valued at around $12.92 million. mPhase Technologies, Inc., a development stage company, develops power cells and related products through the use of microfluidics, microelectromechanical systems, and nano-technology.

Has XDSL Found The Bottom And Ready To Gain Momentum? Find Out Here

Growlife Inc (OTC:PHOT) moved -3.88 percent lower at $0.0620 and is trading between $0.06 and $0.06 after opening the day at $0.06. Its performance over the last five days remained -7.46%, which stands at 19.48% for a month. Going back further than one month, 1-year performance after recent close was -37.37%. Growlife, Inc., through its subsidiaries, manufactures and markets horticulture and lifestyle products in the United States and internationally.

Why Should Investors Buy PHOT After the Recent Fall? Just Go Here and Find Out

AMARANTUS BIOSCI INC (OTC:AMBS)’s shares down today, declining -4.46 percent to 0.0750. The stock is down around -43.18% in 2013 and -16.67% for the last 12 months. Around 1.25 million shares changed hands so far in this session compared to an-average trading volume of 5.80 million shares. Amarantus BioScience, Inc., a development-stage biotechnology company, focuses on the discovery and development of therapeutic proteins and biologics for the treatment of Parkinson?s disease, traumatic brain injury (TBI), and other human diseases in the United States.

Will AMBS Get Buyers Even After The Recent Rally? Find Out Here

About Value Penny Stocks
Value Penny Stocks was made by Two Active traders Steve and Wilson whom have make a platform for trader in order to provide traders #1 Penny Stock Newsletter which actually give your value to your money and make your portfolio full of Profits. We concentrate on value small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devotes ourselves in understanding the overall market situations, and use this knowledge in order to gain a better perception during our stock picking decisions.

Disclaimer
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.

Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/